Investigating the Impact of Delivery Routes for Exon Skipping Therapies in the CNS of DMD Mouse Models

Nucleic acid-based therapies have demonstrated great potential for the treatment of monogenetic diseases, including neurologic disorders. To date, regulatory approval has been received for a dozen antisense oligonucleotides (ASOs); however, these chemistries cannot readily cross the blood–brain barr...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Amel Saoudi, Claire Fergus, Talia Gileadi, Federica Montanaro, Jennifer E. Morgan, Vincent P. Kelly, Thomas Tensorer, Luis Garcia, Cyrille Vaillend, Francesco Muntoni, Aurélie Goyenvalle
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2023-03-01
Schriftenreihe:	Cells
Schlagworte:	ASO-based therapy central nervous system intracerebroventricular injection intrathecal injection antisense oligonucleotides exon-skipping
Online-Zugang:	https://www.mdpi.com/2073-4409/12/6/908
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!